Group One Trading, L.P. Incyte Corp Transaction History

Group One Trading, L.P.

$2.2 Billion
Q1 2025

A detailed history of Group One Trading, L.P. transactions in Incyte Corp stock. As of the latest transaction made, Group One Trading, L.P. holds 1,459 shares of INCY stock, worth $98,103. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,459

Holding current value

$98,103

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$60.0 - $75.26 $87,540 - $109,804	1,459 New	1,459 $88,000
Q3 2023 Nov 09, 2023	BUY	$57.77 - $65.93 $626,515 - $715,010	10,845 Added 172.66%	17,126 $989,000
Q2 2023 Aug 09, 2023	BUY	$60.95 - $75.51 $382,826 - $474,278	6,281 New	6,281 $390,000
Q4 2022 Feb 09, 2023	SELL	$67.18 - $84.11 $298,749 - $374,037	-4,447 Reduced 32.67%	9,165 $736,000
Q3 2022 Nov 09, 2022	BUY	$66.18 - $82.86 $517,659 - $648,130	7,822 Added 135.09%	13,612 $907,000
Q2 2022 Aug 11, 2022	SELL	$66.18 - $83.18 $103,439 - $130,010	-1,563 Reduced 21.26%	5,790 $440,000
Q1 2022 May 12, 2022	BUY	$66.02 - $79.71 $470,788 - $568,412	7,131 Added 3212.16%	7,353 $584,000
Q4 2021 Feb 11, 2022	SELL	$63.34 - $74.11 $1.2 Million - $1.4 Million	-18,905 Reduced 98.84%	222 $16,000
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $841,344 - $1.03 Million	12,252 Added 178.21%	19,127 $1.32 Million
Q2 2021 Aug 10, 2021	BUY	$79.87 - $87.53 $2,076 - $2,275	26 Added 0.38%	6,875 $578,000
Q1 2021 May 12, 2021	BUY	$76.02 - $100.5 $273,900 - $362,101	3,603 Added 111.0%	6,849 $557,000
Q4 2020 Feb 10, 2021	BUY	$80.74 - $97.7 $262,082 - $317,134	3,246 New	3,246 $282,000
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $232,921 - $300,331	-2,738 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $89,906 - $132,023	1,212 Added 79.42%	2,738 $285,000
Q1 2020 May 13, 2020	BUY	$63.18 - $85.97 $96,412 - $131,190	1,526 New	1,526 $112,000
Q1 2019 May 13, 2019	SELL	$63.56 - $88.17 $3.18 Million - $4.41 Million	-50,059 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$58.5 - $69.94 $260,793 - $311,792	4,458 Added 9.78%	50,059 $3.18 Million
Q3 2018 Nov 08, 2018	SELL	$61.75 - $74.23 $651,709 - $783,423	-10,554 Reduced 18.79%	45,601 $3.15 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $1.15 Million - $1.58 Million	18,863 Added 50.58%	56,155 $3.76 Million
Q1 2018 May 11, 2018	SELL	$83.06 - $100.98 $3.42 Million - $4.16 Million	-41,166 Reduced 52.47%	37,292 $3.11 Million
Q4 2017 Feb 09, 2018	BUY	$93.56 - $116.6 $5.08 Million - $6.33 Million	54,285 Added 224.57%	78,458 $7.43 Million
Q3 2017 Nov 15, 2017	SELL	$109.15 - $138.27 $612,768 - $776,247	-5,614 Reduced 18.85%	24,173 $2.82 Million
Q2 2017 Aug 14, 2017	BUY	N/A	29,787	29,787 $3.75 Million

Others Institutions Holding INCY

# of Institutions

695

Shares Held

194M

Call Options Held

564K

Put Options Held

331K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Incyte Corp Transaction History